Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical glucose versus saline crossover study in glaucoma
ACTRN12612001134819Phase 2Active, not recruiting
- Sponsor
- Royal Adelaide Hospital
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of glucose in Glaucoma, sponsored by Royal Adelaide Hospital. Primary endpoint: Contrast sensitivity at 12 cycles per degree. Started Jul 2012; status: active, not recruiting.
02
Drugs
glucose
03
Conditions
Glaucoma
Beyond the preview
Go deeper on ACTRN12612001134819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001134819.